MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease

    J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe (New York, NY, USA)

    Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor…
  • 2016 International Congress

    mPower: A smartphone-based study of Parkinson’s disease provides personalized measures of disease impact

    A.D. Trister, E.C. Neto, B.M. Bot, T. Perumal, A. Pratap, A. Klein, E.R. Dorsey, C.M. Tanner, S.H. Friend (Seattle, WA, USA)

    Objective: mPower is a clinical observational study of Parkinson's disease (PD) conducted completely through an iPhone app focused on the ability of mobile devices and…
  • 2016 International Congress

    Quantifying turning behavior in Parkinson’s disease patients using mobile technology

    M. Miller Koop, S.J. Ozinga, J.L. Alberts (Cleveland, OH, USA)

    Objective: To use inertial measurement unit (IMU) data from a mobile device, iPad or iPhone, to quantify PD patients' gait and turning behavior, on and…
  • 2016 International Congress

    Analysis of temporal gait features extracted from accelerometer-based signals during ambulatory walking in Parkinson’s disease

    M. Boutaayamou, M. Demonceau, O. Brüls, J.G. Verly, G. Garraux (Liège, Belgium)

    Objective: To perform a proof-of-concept study showing the utility of versatile algorithms aimed at objectively quantifying the duration of refined gait features during ambulatory walking…
  • 2016 International Congress

    Technology use habits and preferences of a population with Parkinson’s disease and their care partners

    J.M. Dean (Boulder, CO, USA)

    Objective: To ascertain the current utilization of Internet, app-based and wearable technologies among individuals with Parkinson's disease. Background: The Davis Phinney Foundation for Parkinson's disseminated…
  • 2016 International Congress

    Spatial accuracy and reliability of the Microsoft Kinect V2 in the assessment of joint movement in comparison to marker-based motion capture (Vicon)

    K. Otte, B. Kayser, S. Mansow-Model, A.U. Brandt, J. Verrel, T. Schmitz-Hübsch (Berlin, Germany)

    Objective: Evaluation of Microsoft Kinect V2 against standard motion capture. Background: Augmentation of clinical Motor testing with instrumental assessment has been proposed to increase objectivity.…
  • 2016 International Congress

    Evaluation of kinematic parameters of potential clinical use extracted from Microsoft Kinect V2 motor assessments

    K. Otte, B. Kayser, S. Mansow-Model, A.U. Brandt, J. Verrel, T. Schmitz-Hübsch (Berlin, Germany)

    Objective: To evaluate movement parameters for clinical use extracted from Microsoft Kinect V2 joints. Background: Instrumental motor assessment has been proposed to increase objectivity but…
  • 2016 International Congress

    Quantitative assessment of advanced therapies in Parkinson’s disease using the Parkinson kinetigraph (PKG)

    R.L. Blaze, J. Tan, A.H. Evans (Parkville, Australia)

    Objective: Our aim was to establish whether objective measurements using the Parkinson's Kinetigraph can detect differences between patients undergoing different advanced therapy with either deep…
  • 2016 International Congress

    Efficacy and safety of a L-dopa delivery and monitoring medical device

    Y.G. Tirat-Gefen (Fairfax, VA, USA)

    Objective: The objective of this study is to evaluate algorithms in a medical device for l-dopa delivery and monitoring. This wearable medical device will measure…
  • 2016 International Congress

    Novel THAP1 missense mutation leading to focal and segmental dystonia

    D. Crosiers, C. Van Broeckhoven, P. Cras (Edegem, Belgium)

    Objective: We have identified a novel heterozygous missense mutation in THAP1 (DYT6 locus) in a patient suffering from craniocervical and upper limb dystonia. We describe…
  • « Previous Page
  • 1
  • …
  • 1401
  • 1402
  • 1403
  • 1404
  • 1405
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley